Cerebain Biotech announced that the company has appointed Mustafa Husain, M.D., to its Scientific Advisory Board. Dr. Husain is a preeminent researcher with expertise in device-based research for Neuropsychiatric Disorders. Currently Dr. Husain is Professor of Psychiatry, Neurology & Medicine at Duke University Medical Center and member of Duke Institute for Brain Sciences.
Cerebain Biotech Corp.
Equities
CBBT
US15672M1062
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+43.87% | 56.65B | |
-6.56% | 39.44B | |
+39.13% | 39.03B | |
-11.17% | 26.86B | |
+13.48% | 26.75B | |
-21.36% | 19.03B | |
+0.74% | 12.28B | |
+26.16% | 12.26B | |
+27.69% | 12.04B |